High IL-15 expression is linked to a decreased recurrence in patients with colorectal cancer [39,43], and an increased level of plasma IL-15 was associated with clinical benefit of checkpoint inhibitors in lung cancer patients [40]. This evidence concerns the gene IL15 and lung cancer.